ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Concept Discussion: Five Experimental Stages to Establish the Methodologies for Organ Farming

R. F. Smith

George Washington University, Bristow, VA

Meeting: 2020 American Transplant Congress

Abstract number: D-319

Keywords: Bioengineering, Donation, Economics, Ethics

Session Information

Session Name: Poster Session D: Cellular Therapies, Tissue Engineering / Regenerative Medicine

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Most of the technologies to grow human organs in vitro already exist, but experimentation (and policy development support) will be required to ensure that:

*Methods: 1) ethical boundaries for the experimental testing of human “organogenic pod” tissue development are adopted into policy (organogenic pods consist of all of the major organs from the neck down to the thoracic and abdominopelvic cavities);

2) clinical-grade laboratory facilities are established for clinical trials (ARMI);

3) an experimental incubation system (to be a U.S. trade secret) can support growing pods of primate and eventually human organs practically indefinitely;

4) a genetic subtraction technique (CRISPR) can be combined with “brain on a chip” technology to make organogenic pods;

5) experimental growth acceleration protocols result in accelerated, non-cancerous organogenic pod growth.

Stages 1-2 are already underway (R. Franklin Smith et. al. 2020 policy paper recommendations and ARMI tissue foundry)

*Results: Stage 3 will likely require at least 6-9 months of testing;

Stage 4 will likely require at least 5-10 years of testing;Stage 5 may also require 5-10 years of testing

*Conclusions: It is expected that U.S. health insurance providers and independent analysts will recommend to the U.S. public pricing options for how health insurance companies will defray the costs required to grow and maintain organogenic pods between their patients and subscribers.

This poster will also frame a discussion on the advantages of the organ farming approach over current bioprinting trends.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Smith RF. Concept Discussion: Five Experimental Stages to Establish the Methodologies for Organ Farming [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/concept-discussion-five-experimental-stages-to-establish-the-methodologies-for-organ-farming/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences